Menu
GeneBe

20-3661053-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3

The NM_022139.4(GFRA4):c.283G>A(p.Glu95Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000031 in 1,450,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000034 ( 0 hom. )

Consequence

GFRA4
NM_022139.4 missense

Scores

10
7
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.68
Variant links:
Genes affected
GFRA4 (HGNC:13821): (GDNF family receptor alpha 4) The protein encoded by this gene is a member of the GDNF receptor family. It is a glycosylphosphatidylinositol(GPI)-linked cell surface receptor for persephin, and mediates activation of the RET tyrosine kinase receptor. This gene is a candidate gene for RET-associated diseases. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.825

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GFRA4NM_022139.4 linkuse as main transcriptc.283G>A p.Glu95Lys missense_variant 2/6 ENST00000290417.7
GFRA4NM_145762.3 linkuse as main transcriptc.283G>A p.Glu95Lys missense_variant 2/5
GFRA4XM_005260793.2 linkuse as main transcriptc.283G>A p.Glu95Lys missense_variant 2/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GFRA4ENST00000290417.7 linkuse as main transcriptc.283G>A p.Glu95Lys missense_variant 2/61 NM_022139.4 P1Q9GZZ7-2
GFRA4ENST00000319242.8 linkuse as main transcriptc.283G>A p.Glu95Lys missense_variant 2/51 Q9GZZ7-1
GFRA4ENST00000477160.1 linkuse as main transcriptc.283G>A p.Glu95Lys missense_variant, NMD_transcript_variant 2/41 Q9GZZ7-3

Frequencies

GnomAD3 genomes
AF:
0.00000660
AC:
1
AN:
151580
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000307
AC:
2
AN:
65192
Hom.:
0
AF XY:
0.0000520
AC XY:
2
AN XY:
38466
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000822
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000339
AC:
44
AN:
1299106
Hom.:
0
Cov.:
37
AF XY:
0.0000343
AC XY:
22
AN XY:
640820
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000458
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000403
Gnomad4 OTH exome
AF:
0.0000187
GnomAD4 genome
AF:
0.00000659
AC:
1
AN:
151690
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74140
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000195
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 08, 2023The c.283G>A (p.E95K) alteration is located in exon 2 (coding exon 2) of the GFRA4 gene. This alteration results from a G to A substitution at nucleotide position 283, causing the glutamic acid (E) at amino acid position 95 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.80
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Uncertain
0.020
Cadd
Pathogenic
31
Dann
Pathogenic
1.0
Eigen
Pathogenic
0.71
Eigen_PC
Uncertain
0.63
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.95
D;D
M_CAP
Pathogenic
0.89
D
MetaRNN
Pathogenic
0.83
D;D
MetaSVM
Uncertain
0.0056
D
MutationAssessor
Uncertain
2.7
M;M
MutationTaster
Benign
1.0
D;D
PrimateAI
Pathogenic
0.94
D
PROVEAN
Uncertain
-3.7
D;D
REVEL
Uncertain
0.53
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;D
Vest4
0.64
MutPred
0.64
Gain of methylation at E95 (P = 0.0115);Gain of methylation at E95 (P = 0.0115);
MVP
0.86
MPC
1.1
ClinPred
0.85
D
GERP RS
4.3
Varity_R
0.88
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs562272020; hg19: chr20-3641700; API